{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"17"},{"groupId":"OG001","value":"19"}],"title":"Complete CIV Control"},{"measurements":[{"groupId":"OG000","value":"43"},{"groupId":"OG001","value":"48"}],"title":"Partial CIV Control"},{"measurements":[{"groupId":"OG000","value":"23"},{"groupId":"OG001","value":"15"}],"title":"Failed CIV Control"}],"denoms":[{"counts":[{"groupId":"OG000","value":"83"},{"groupId":"OG001","value":"82"}],"units":"Participants"}],"title":"Acute Phase"},{"categories":[{"measurements":[{"groupId":"OG000","value":"35"},{"groupId":"OG001","value":"31"}],"title":"Complete CIV Control"},{"measurements":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"28"}],"title":"Partial CIV Control"},{"measurements":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"10"}],"title":"Failed CIV Control"}],"denoms":[{"counts":[{"groupId":"OG000","value":"75"},{"groupId":"OG001","value":"69"}],"units":"Participants"}],"title":"Delayed Phase"}],"denoms":[{"counts":[{"groupId":"OG000","value":"83"},{"groupId":"OG001","value":"82"}],"units":"Participants"}],"description":"CIV = Chemotherapy-Induced Vomiting. Total Duration of Study includes both acute and delayed phases. Acute Phase - bands will be worn on each day of the chemotherapy course and for 24 hours after the last chemotherapy dose. Delayed Phase - Bands will continue to be worn for a maximum of 7 days or until the next chemotherapy cycle starts, whichever comes first. A breakthrough antiemetic agent is defined as a medication that is administered or taken in order to relieve or treat (rather than prevent) nausea or vomiting. An antiemetic agent that is prescribed and/or administered on an \"as needed\" basis is considered to be a breakthrough antiemetic. Complete CIV Control during the acute and delayed phases is defined as no emetic episodes and no breakthrough anti-emetic agents administered during the phase of interest. Partial CIV Control is defined as 1 or 2 emetic episodes in any 24 ho","groups":[{"description":"Patients wear Sea-Band acupressure wristbands on each wrist beginning approximately 30 minutes prior to the first cisplatin-containing chemotherapy course and continually for 24 hours after the last chemotherapy dose (acute phase), and for a maximum of 7 days or until the next chemotherapy course starts (delayed phase). Patients are allowed to take bands off intermittently (up to 4 times a day, for no more than 15 minutes each time) to relieve pressure or to bathe. Patients also receive standard of care anti-emetic prophylaxis comprising granisetron, ondansetron, or dexamethasone during chemotherapy according to institutional or physician preference.\n\nReal Acupressure Band: Acupressure wristband","id":"OG000","title":"Arm I- Real Acupressure Bands"},{"description":"Patients wear placebo wristbands on each wrist and receive standard of care anti-emetic prophylaxis during chemotherapy as patients in arm I.\n\nPlacebo Acupressure Band: Sham wristband","id":"OG001","title":"Arm II- Placebo Acupressure Bands"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"The overall number of participants analyzed is 83 participants in Arm I and 82 participants in Arm II. In the acute phase, 165 patients provided at least 1 PeNAT (Pediatric Nausea Assessment Tool) score. In the delayed phase, 144 patients contributed at least 1 PeNAT score.","reportingStatus":"POSTED","timeFrame":"Maximum of 14 days","title":"Comparison of Control of CIV During the Acute and Delayed Phase of Chemotherapy","type":"SECONDARY","unitOfMeasure":"Participants"}